Aclasta Injection 5mg

About Aclasta Injection 5mg

Aclasta Injection 5mg Uses

• Treatment of postmenopausal osteoporosis to reduce fracture risk
• Treatment of osteoporosis in men
• Treatment and prevention of glucocorticoid induced osteoporosis
• Treatment of Paget's disease of bone
• Prevention of new clinical fractures after a recent hip fracture

Aclasta Injection 5mg Benefits

• Increases bone mineral density with a single yearly infusion
• Reduces the risk of spine, hip and other fractures
• Improves treatment compliance since dosing is needed only once a year
• Slows abnormal bone turnover in Paget's disease

What Experts Say

Doctors across Pakistan prescribe zoledronic acid as a once yearly intravenous infusion because it binds tightly to bone mineral and suppresses excess osteoclast activity for many months at a time. This long acting mechanism reduces the burden of daily or weekly bisphosphonate tablets for older patients who often struggle with regular dosing schedules.

Physicians recommend checking kidney function and blood calcium and vitamin D levels before every infusion, since zoledronic acid is cleared through the kidneys and can trigger a temporary drop in blood calcium. Adequate hydration on the day of infusion also helps lower the chance of short term kidney strain in older or dehydrated patients.

Specialists generally reserve zoledronic acid for patients with confirmed low bone density, a prior fragility fracture, or long term steroid use that weakens bone. A dental check is advised before the first dose, since rare jaw bone problems have occasionally been linked to long term bisphosphonate therapy.

Drug Class

• Bisphosphonate
• Bone Resorption Inhibitor

Aclasta Injection 5mg formula

• Zoledronic Acid

Available forms

• Injection

How to use Aclasta Injection 5mg?

• Administered only by a doctor or trained healthcare professional as a slow intravenous infusion over at least 15 minutes
• Given once a year for osteoporosis treatment, or once every two years for prevention in some cases
• Blood tests for kidney function and calcium are usually done before each infusion
• Patients are advised to take a calcium and vitamin D supplement before and after the infusion unless the doctor advises otherwise
• Drink plenty of water on the day of and the day before the infusion to stay well hydrated

Drug Interactions

• Aminoglycoside Antibiotics: May increase the risk of low blood calcium when used together with zoledronic acid
• Loop Diuretics: Combined use can raise the risk of low blood calcium, especially in dehydrated patients
• Nephrotoxic Drugs: Other medicines that affect the kidneys, such as NSAIDs, may add to the kidney related risks of zoledronic acid
• Thalidomide: Combined use with corticosteroids and thalidomide may raise the risk of kidney problems in multiple myeloma patients

Risks and warnings

• Kidney Impairment: Not recommended in patients with severe kidney disease since the drug is cleared by the kidneys
• Hypocalcemia: Can lower blood calcium, so existing low calcium levels must be corrected before the infusion
• Osteonecrosis of the Jaw: Rare but serious jaw bone damage has been reported, mostly after dental surgery during long term use
• Atypical Femur Fracture: Long term use has been linked to unusual thigh bone fractures in rare cases
• Pregnancy and Breastfeeding: Not recommended since safety in pregnant or breastfeeding women has not been established

Aclasta Injection 5mg Side Effects

• Flu like symptoms such as fever, chills and body aches after the infusion
• Headache
• Nausea and vomiting
• Muscle and joint pain
• Low blood calcium or phosphate levels
• Fatigue
• Injection site redness or swelling
• Dizziness

Storage Conditions

• Store the unopened vial at room temperature, below 30°C, away from direct sunlight
• Do not freeze the solution
• Keep the vial in its original carton until it is ready to be used
• Once opened, use immediately or as directed by the healthcare provider administering it
• Keep out of reach of children